ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
0.8999
-0.0595 (-6.20%)
At close: Aug 14, 2026, 4:00 PM EDT
0.9429
+0.0430 (4.78%)
After-hours: Aug 14, 2026, 7:51 PM EDT
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $22.74 million as of August 14, 2026. Its market cap has decreased by -67.47% in one year.
Market Cap
22.74M
Enterprise Value
25.27M
1-Year Change
-67.47%
Ranking
Category
Stock Price
$0.90
ChartMarket Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $22.74M, a decrease of -71.40%. That is a compound annual growth rate of -22.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 24.00M | -53.67% |
| Dec 31, 2025 | 51.80M | 572.73% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
| Aug 3, 2021 | 79.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enlivex | 27.16M |
| GridAI Technologies | 26.84M |
| Evaxion | 26.78M |
| CEL-SCI | 26.04M |
| Atossa Therapeutics | 25.55M |
| Cerenome | 25.47M |
| Barinthus Biotherapeutics | 24.51M |
| Jasper Therapeutics | 24.18M |